A recent study from Case Western Reserve University reveals that a strong majority of patients with inflammatory bowel disease (IBD) believe cannabis and CBD oil significantly help manage their symptoms. Over half of IBD patients surveyed reported current cannabis use, with 63.2% saying it eased symptoms like abdominal pain, stress, and nausea. Similarly, 56.6% found CBD oil effective, with the benefits more pronounced in those with Crohn’s disease rather than ulcerative colitis. Nearly 20% of respondents said these treatments helped them reduce opioid use, and 14.5% even reported remission. Support for medical cannabis was high among both patients and non-IBD controls. The study highlights the growing acceptance of cannabis-based therapies, while emphasizing the need for more clinical research and guidance.
Read the full story at The Marijuana Herald.